Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...
Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, it is important that ...
Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is being ...
Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to dissolve at a ...
Stockholders expected to receive $0.028 and $0.045/shr Co. writes down value of clinical-stage drug Riquent Oct 15 (Reuters) - La Jolla Pharmaceutical Co has called a special meeting of stockholders ...
Researchers found a commercial deworming tablet released only 10% of its drug content in dissolution testing, prompting investigation of new formulations designed to improve drug release and extend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results